MBCBrainMets.org – Our New Partner!
Our newest Metastatic Trial Search partner is MBCBrainMets.org. The new website was recently launched to fill an unmet need for information and support for people...
Read MoreBispecific Antibodies: An Emerging Class Of MBC Drugs
Bispecific antibodies are an emerging class of drugs in breast cancer clinical research. By binding to two distinct targets, a bispecific antibody can do two jobs...
Read MoreMBC and NED
The term No Evidence of Disease (NED) means that the cancer is not detectable in a person’s body with currently available tests such as imaging and blood...
Read More“Standard of Care” for MBC
“Standard of care” is the term used for the best existing treatment option in the clinic. Standard of care varies for different subtypes of MBC and is...
Read MoreTreatment for MBC While Pregnant
MBC is sometimes detected in pregnant women. Breast cancer does not pass to the unborn baby and does not harm the baby. There is no standard of care recommended...
Read MoreMBC-Related News from SABCS
The Annual San Antonio Breast Cancer Symposium was held on December 7-10, 2021. Read below for highlights from the meeting, including promising results about a...
Read MoreAdvanced Breast Cancer Conference 2021
Advanced Breast Cancer (ABC6; ABC Global Alliance) was held virtually on November 4-6, 2021. Read below for news coming out of this conference, including a report...
Read MoreScan Anxiety
People with MBC periodically undergo imaging such as CT scans, MRI, and PET scans to look for response to treatment and disease progression. Scan anxiety, which...
Read MoreTreatment Strategies for Triple-Positive MBC
MBC that is positive for both hormone receptors (estrogen receptors/ER and progesterone receptors/PR) and HER2 is called triple positive. Approximately 10% of MBC...
Read MoreSEARCH OUR SITE
for past articles or specific information.